Human Angiotensin-Converting Enzyme 2 (hACE2)

Human Angiotensin-Converting Enzyme 2 (hACE 2) is an important enzyme in the renin-angiotensin system, known for its role in regulating blood pressure and inflammation. Applications of ACE2 glycopeptides are diverse and impactful. They are central to COVID-19 research because ACE2 serves as the primary receptor for the SARS-CoV-2 virus, making these glycopeptides targets for developing antiviral drugs and vaccines. In the field of cardiovascular medicine, ACE2 glycopeptides are studied for their role in regulating blood pressure and may be used to develop treatments for hypertension and heart failure. Additionally, these glycopeptides are used as biomarkers for assessing cardiovascular conditions and understanding the function of the renin-angiotensin system. They also play a role in immunological research, where they help to explore the mechanisms of viral infections and immune responses.